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INTRODUCTION AND OBJECTIVES:
Necrotizing enterocolitis (NEC) is the
leading gastrointestinal cause of death in
premature infants. Postnatal enterally
administered Heparin-Binding EGF-like
Growth Factor (HB-EGF) decreases the
incidence and severity of intestinal injury in
a neonatal rat model of NEC. In this study,
we
hypothesized
that
NEC-induced
inflammation would increase the expression
of cytokines in the autonomic control regions
of the nucleus tractus solitarii (NTS) and that
prenatal administration of HB-EGF would
decreased the incidence of NEC and
associated neuroinflammation.
METHODS: HB-EGF 800 µg/kg/dose, was
delivered by means of tail vein injection or
intraperitoneally 2 hours prior to delivery of
the rat pups. Rat pups were delivered
prematurely by C-section and subjected to
NEC protocol. Pups were sacrificed upon
signs of NEC and intestines were harvested
and graded. Cytokine expression in the pup
brain (IL-1β, IL-6, TNFα) was assessed.

RESULTS: Compared to untreated pups, the
prenatal administration of HB-EGF to
pregnant female rats significantly decreases
the incidence and severity of NEC in rat pups
with best results seen when HB-EGF is
administered in an intraperitoneal fashion 2
hours before C-section. (62.9% vs 30%*, p
=0.02) IL-6 was not significantly different in
the untreated pups versus pups that received
HB-EGF prenatally (p= 0.75) but IL-1β and
TNFα were significantly reduced by tail
injections at 2 hours prior to birth (p =0.0018
IL-1β and p=0.00005 TNFα).
CONCLUSIONS:
Prenatal
HB-EGF
administration decreases the incidence and
severity of experimental NEC and reduces
the inflammatory markers. This suggests a
novel prophylactic strategy that could have
beneficial neurodevelopmental effects in
NEC patients.
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